Ethinylestradiol/norelgestromin

Ethinylestradiol/norelgestromin
Combination of
Ethinylestradiol Estrogen
Norelgestromin Progestogen
Clinical data
Trade names Ortho Evra, Xulane
MedlinePlus a602006
Pregnancy
category
  • US: X (Contraindicated)
Routes of
administration
Transdermal (patch)
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
  • None
KEGG

Ethinylestradiol/norelgestromin (brand names Ortho Evra, Evra, Xulane) is a contraceptive patch containing the estrogen ethinylestradiol and the progestin norelgestromin which is marketed in the United States, Canada, Europe, and elsewhere in the world.[1] As of December 2016, the Ortho Evra product has been discontinued in the U.S. while the Xulane product continues to be marketed in this country.[1]

See also

References

  1. 1 2 "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 22 December 2016.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.